Stay updated on Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The clinical trial record for a Phase 2 study of nivolumab with relatlimab or ipilimumab in metastatic melanoma is displayed, including its terminated status due to loss of funding and its study details. The record also includes results-related measures, eligibility criteria, and a study protocol document.
    Difference
    58%
    Check dated 2026-10-26T15:13:40.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 while the page remained a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T14:51:45.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T16:12:39.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a generic header/footer, replacing the usual study details and indicating the record is temporarily inaccessible rather than content updates.
    Difference
    19%
    Check dated 2026-09-21T22:24:00.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5. This indicates a minor update to the page’s revision history.
    Difference
    0.1%
    Check dated 2026-08-31T18:48:46.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    A new site revision label v3.6.5 was added, replacing the previous revision label v3.6.4.
    Difference
    0.1%
    Check dated 2026-08-10T13:28:01.000Z thumbnail image

Stay in the know with updates to Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page.